84 related articles for article (PubMed ID: 7508099)
1. High prevalence of anti-HCV among renal patients with or without renal failure.
Gerakis A; Kapasouri E; Hadjidimitriou G; Billis A
Nephrol Dial Transplant; 1993; 8(11):1307-8. PubMed ID: 7508099
[No Abstract] [Full Text] [Related]
2. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
[TBL] [Abstract][Full Text] [Related]
3. [Investigation on anti-HCV antibody in Shashi District].
Wu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):331-3. PubMed ID: 7512448
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to hepatitis C virus in Omani patients with renal disease.
al-Dhahry SH; Aghanashinikar PN; al-Hasani MK; Buhl MR; Daar AS
Transplant Proc; 1992 Oct; 24(5):1938-9. PubMed ID: 1384203
[No Abstract] [Full Text] [Related]
5. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis-C virus (HCV) in peritoneal dialysis.
Krautzig S; Tillmann H; Wrenger E; Manns M; Koch KM; Brunkhorst R
Clin Nephrol; 1994 Feb; 41(2):120. PubMed ID: 7516274
[No Abstract] [Full Text] [Related]
7. [Prevalence of anti hepatitis C antibodies in patients with chronic renal failure receiving conservative therapy].
de Los Ríos R; Bussalleu A; Hurtado A; Valdivia J; Huerta Mercado J; Battilana C; Pala M; Pinto JL; Piscoya A; Cedrón H
Rev Gastroenterol Peru; 2006; 26(3):265-70. PubMed ID: 17053822
[TBL] [Abstract][Full Text] [Related]
8. [The prevalence of anti-HCV antibodies in a population of Sicilian hemodialysis patients].
Soresi M; Montalto G; Galione A; Carroccio A; Bonfissuto G; Di Martino D; Annaloro R; Notarbartolo A
Recenti Prog Med; 1994 Sep; 85(9):415-8. PubMed ID: 7938871
[No Abstract] [Full Text] [Related]
9. [Anti HCV in hemodialyzed patients: reduction of the prevalence and association with epidemiological variables].
Padrone M; Corallini O; Cocozzella D; Malca M; Borzi S; Barrio M; Adrover RE; Cuffini AM; Gomez C; Giamona AM; Brawlasky G; Newmann P; Dell Amo M; Fraquelli E; Curciarello JO
Acta Gastroenterol Latinoam; 1999; 29(3):91-4. PubMed ID: 10533653
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
[TBL] [Abstract][Full Text] [Related]
11. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection.
Orloff SL; Stempel CA; Wright TL; Tomlanovich SJ; Amend WJ; Stock PG; Melzer JS; Vincenti F
Clin Transplant; 1995 Apr; 9(2):119-24. PubMed ID: 7599400
[TBL] [Abstract][Full Text] [Related]
14. [HCV-positive blood donors. Risk factors].
Iraporda V; Gil L; Moreda J; Fernández P; González J; Velicia R
Rev Esp Enferm Dig; 1995 Feb; 87(2):179-80. PubMed ID: 7538317
[No Abstract] [Full Text] [Related]
15. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
16. Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective study.
Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Crepaldi M; Pagano A; Locatelli F
Nephrol Dial Transplant; 1994; 9(11):1611-5. PubMed ID: 7532839
[TBL] [Abstract][Full Text] [Related]
17. [Serological investigation on intrafamilial transmission of HCV infection].
Wang S; Huang Y; Yu Z
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Feb; 15(1):34-7. PubMed ID: 7521795
[TBL] [Abstract][Full Text] [Related]
18. [The prevalence of antibodies to the hepatitis C virus (HCV) in patients with post-transfusional hepatitis and blood donors in Moldova].
Iancu L; Turcu T; Apetrei C; Porumb S; Dimitriu S; Donţu G; Mândru R; Moraru E; Duca M
Bacteriol Virusol Parazitol Epidemiol; 1993; 38(1-2):76-80. PubMed ID: 9132116
[No Abstract] [Full Text] [Related]
19. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
